MCL1 and posterior cortical atrophy: ,38,39 However, neither LNCaP95 nor VCaP harbor MCL1 copy number alternations, and it will be important to interrogate the underlying mechanisms that drive sensitivity to MCL1 inhibition in these models to support the development of biomarker stratified treatment approaches for therapies targeting MCL1 in lethal PCa.22